A 4-year-old child with Kawasaki disease is in the acute phase and has developed coronary artery aneurysms. The child's temperature is 102.8°F (39.3°C), and the parents are asking about fever management. What is the most appropriate nursing intervention?

In Kawasaki disease with coronary artery involvement, aspirin is contraindicated due to increased bleeding risk from anticoagulation therapy and potential for Reye's syndrome in children.

Kawasaki disease is a systemic vasculitis that primarily occurs in children under 5 years of age, and can lead to serious cardiac complications, particularly coronary artery aneurysms. When a child with Kawasaki disease develops coronary artery aneurysms, the management approach becomes much more complex, requiring careful consideration of all interventions, including fever management.

The most critical aspect of caring for a child with Kawasaki disease who has developed coronary artery aneurysms is avoiding medications that may increase bleeding risk or cause additional complications. Aspirin is commonly used as an antipyretic in many conditions, but it is specifically contraindicated in children with Kawasaki disease who have developed coronary artery aneurysms. This is because these patients are typically receiving anticoagulation therapy to prevent thrombus formation in the dilated coronary arteries, and aspirin can significantly increase the risk of bleeding complications.

Additionally, aspirin use in children with viral or inflammatory illnesses carries the risk of Reye's syndrome, a rare but potentially fatal condition affecting the liver and brain. The combination of anticoagulation therapy and the underlying inflammatory process in Kawasaki disease makes aspirin use particularly hazardous.

The appropriate nursing intervention is to avoid aspirin administration and consult with the physician regarding safe alternatives for fever management. The physician may recommend acetaminophen or other non-aspirin antipyretics that do not interfere with coagulation. This collaborative approach ensures that fever management is both effective and safe for the child's specific condition.

Appropriate fever management in these patients requires balancing the need for comfort and temperature control with the critical safety considerations related to cardiac complications and anticoagulation status.

Clinical Context & Pathophysiology
Kawasaki disease (KD) is an acute, self-limited inflammatory vasculitis of unknown etiology that predominantly affects medium-sized arteries, particularly the coronary arteries. In the acute phase, a child with KD who has already developed coronary artery aneurysms represents a high-risk thrombotic state. The inflamed, damaged endothelium within the aneurysm activates platelets and the coagulation cascade, creating a profound risk for thrombus formation and subsequent myocardial infarction, which is the most significant long-term morbidity in KD ^[1].

Rationale for the Correct Answer (Option 4)
The most appropriate intervention is to avoid giving aspirin and consult with the physician about fever management. This is a critical safety issue. The standard of care for KD in the acute phase involves high-dose acetylsalicylic acid (aspirin) for its anti-inflammatory and antiplatelet effects. Once the fever subsides, the dose is transitioned to a low, antiplatelet dose, which is often continued long-term specifically because of the presence of coronary artery aneurysms. The child's current fever of 102.8°F (39.3°C) is an expected manifestation of the acute inflammatory process. If a nurse were to independently administer an additional antipyretic like acetaminophen or ibuprofen, it could mask the fever, which is the primary clinical marker used to determine when to transition from high-dose to low-dose aspirin therapy. Masking the fever could lead to a premature or inappropriate dosing change. Furthermore, the parents' question presents a safety risk if they were to give an over-the-counter antipyretic without the team's knowledge, as it could interact with the prescribed aspirin regimen or obscure the clinical picture. The nurse's role is to recognize this risk, hold any non-prescribed antipyretics, and immediately consult the physician to clarify the fever management plan within the context of the child's complex aspirin therapy and aneurysms.

Analysis of Incorrect Options
- Option 1 (Administer acetaminophen): This is contraindicated without a direct order in this specific context. Adding acetaminophen to a patient on high-dose aspirin for KD can confound the assessment of the aspirin's therapeutic effect on fever and inflammation, which guides critical treatment decisions ^[1].
- Option 2 (Apply cooling blankets): External cooling measures like cooling blankets are generally avoided in the acute febrile phase of KD. They can cause shivering, which paradoxically raises the core body temperature and increases metabolic demand and discomfort. More importantly, they do not address the underlying inflammatory vasculitis and can mask a key indicator of disease activity.
- Option 3 (Encourage fluids and tepid sponge baths): While maintaining hydration is essential supportive care, tepid sponge baths are no longer routinely recommended for fever management in children as they offer minimal benefit and can cause discomfort and shivering. This option fails to address the central safety concern related to the child's specific medication regimen and high-risk cardiac status.

Nursing Implications for NCLEX-RN
The core of this question tests the nurse's ability to anticipate a serious drug-disease interaction and practice within the scope of safe medication administration. The presence of coronary artery aneurysms elevates the child's care from standard supportive fever management to a high-acuity situation where the timing and dosing of antiplatelet therapy are critical to preventing life-threatening thrombosis. The nurse must understand that in KD, fever is not just a symptom to be eliminated but a key clinical parameter guiding pharmacotherapy. Any intervention that could mask this sign without the prescriber's knowledge is a significant patient safety error. The correct action is to recognize the potential for harm, withhold the unapproved intervention, and communicate the concern to the physician to ensure the fever management strategy aligns with the child's prescribed anti-thrombotic regimen ^[1].